http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3352735-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2403aad8bbbf284fed86d63332054c16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee8c4c660b89ebc23eda42d96256284f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2a5d9e06d07321b9ad9e1dcb027b5f
publicationDate 2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3352735-A1
titleOfInvention Sustained release olanzapine formulations
abstract The disclosure is directed to methods of treating schizophrenia or bipolar disorder by subcutaneously administering a sustained-release dosage form of olanzapine, or a pharmaceutically acceptable salt thereof. Methods of subcutaneously administering olanzapine, or a pharmaceutically acceptable salt thereof, are also described.
priorityDate 2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66890536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227304008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135566032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227825851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227197042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135566052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13580495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8468

Total number of triples: 61.